This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 7Inflammatory Bowel Disease
- 1Adverse Outcomes
- 1Antibiotic Resistance
- 1Childhood Diagnosis
- 1Chronic Disease
- 1Claudin-2
- 1Bedard, Katherine
- 1Bihari, Allison KJ
- 1Kroeker, Karen I
- 1Millan, Braden, T
- 1Premraj, Nilanjani
- 1Rashed, Reem A
-
Adherence to Clinical Care Protocols for Inflammatory Bowel Disease and Evaluation of a Clinical Decision Support System to Improve Adherence
DownloadSpring 2020
Clinical care pathways have been developed with the goal to standardize and improve quality of care. At the University of Alberta, clinical care pathways have been developed, and are currently in use, for inflammatory bowel disease patents experiencing disease flare. However, there is limited...
-
Exploring the Association Between Frailty and Adverse Clinical Outcomes in Inflammatory Bowel Disease
DownloadFall 2022
Background and Rationale: Chronological age does not always accurately reflect “biological age”, or the extent of physiological reserve an individual possesses to endure stressors. The concept of physiological reserve is best represented by frailty; a multifaceted syndrome or state that...
-
Fall 2016
Background: Fecal Microbial Transplantation (FMT) has gained popularity due to its efficacy in the treatment of recurrent Clostridium difficile infection (RCDI). RCDI is associated with prolonged courses of antibiotics with high recurrence rates following the initial resolution of symptoms. ...
-
Isomaltodextrin dose-dependently reduces colitis development in HLA-B27 rat colitis model with associated changes to gut microbiota composition and short chain fatty acid production
DownloadFall 2021
Prevalence rates for inflammatory bowel diseases (IBD) worldwide have been drastically increasing over recent decades. IBD is characterized by altered intestinal microbiome (i.e. dysbiosis), described by reduced strict butyrate-producing anaerobes versus increased facultative anaerobes in...
-
The Characterization and Assessment of Transition Success in Young Adults with Inflammatory Bowel Disease
DownloadFall 2024
Canada has one of the highest incidence rates of inflammatory bowel disease (IBD) worldwide, particularly among adolescents and young adults. As the incidence of pediatric-onset IBD is projected to increase in the upcoming years, more patients will need to transition from pediatric to adult care....
-
THE EFFECT OF β-FRUCTANS ON INTESTINAL PERMEABILITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION
DownloadFall 2023
Introduction: β-fructans are non-digestible fermentable carbohydrates that are metabolized by commensal gut bacteria such as Faecalibacterium prausnitzii and Roseburia spp. By-products of β-fructans fermentation include short-chain fatty acids, shown to improve intestinal epithelial integrity and...
-
THE PSYCHOSOCIAL FUNCTIONING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN EARLY ADULTHOOD IS IMPAIRED
DownloadFall 2012
Inflammatory bowel disease is a chronic disease that is often diagnosed in childhood and adolescence. The objective of this study was to assess the impact of a diagnosis of IBD on the psychosocial functioning in early adulthood. This was a questionnaire-based cross-sectional study comparing...